Filters

Documents

Showing 25 of 797 items meeting your criteria.

Type	Category	Supplier

KRIBIOLISA Eculizumab ELISA Flyer KRIBIOLISA Eculizumab ELISA and Anti-Eculizumab ELISA product flyer.
Documents	ELISA	Krishgen Biosystems	View
KRIBIOLISA Atezolizumab ELISA Flyer KRIBIOLISA Atezolizumab ELISA and Anti-Atezolizumab ELISA product flyer.
Documents	ELISA	Krishgen Biosystems	View
KRIBIOLISA Adalimumab ELISA Flyer KRIBIOLISA Adalimumab ELISA and KRIBIOLISA Anti-Adalimumab ELISA product flyer.
Documents	ELISA	Krishgen Biosystems	View
KRIBIOLISA CRM197 ELISA Flyer The KRIBIOLISA™ CRM197 ELISA uses pre-coated streptavidin plates with binding ligand method to estimate the amount of CRM197 in samples.
Documents	ELISA	Krishgen Biosystems	View
Immuno-oncology ELISA Product Guide A range of specific and sensitive assays to measure and monitor popular protein targets.
Documents	ELISA	Krishgen Biosystems	View
Immune Checkpoint ELISA Product Guide A range of specific and sensitive assays to measure and monitor popular immune checkpoint inhibitors and related antibody drugs.
Documents	ELISA	Krishgen Biosystems	View
Glatiramer Acetate ELISA Flyer The Glatiramer ELISA is a competitive immunoassay for the determination of Glatiramer acetate.
Documents	ELISA	Krishgen Biosystems	View
dsRNA ELISA Flyer The worlds first and only ready to use ELISA kit for measurement of dsRNA in your biological samples
Documents	ELISA	Krishgen Biosystems	View
GENLISA Cytokine ELISA Kits Flyer Krishgen Biosystems provide sensitive, validated ELISA kits as a solution for your cytokine testing.
Documents	ELISA	Krishgen Biosystems	View
Bispecific Antibody Drug ELISA CiteAb Award Flyer Krishgen offers a range of ELISAs to quantify bispecific antibody drug levels accurately and quickly in serum and plasma samples.
Documents	ELISA	Krishgen Biosystems	View
Vascular and Dermal Cell Products Flyer Discover iXCells collection of primary vascular cells sourced from both human and animal tissues, accompanied by supporting media. Our range includes cells from cardiac, cardiac microvascular, umbilical vein, dermal, and other vascular origins.
Documents	Primary Cells	iXCells Biotechnologies	View
iPSC Engineering Services - Reprogramming and Gene Editing Flyer iXCells streamlined custom iPSC generation services liberate you from the demanding and labour-intensive task of cell reprogramming and gene editing, allowing you to focus on research.
Documents	Service	iXCells Biotechnologies	View
Primary Human and Animal Renal Cells Flyer iXCells renal cell models offer accurate and reliable insights, enabling researchers to study kidney function, disease mechanisms, and potential therapeutic interventions.
Documents	Primary Cells	iXCells Biotechnologies	View
Custom Cell Isolation Flyer iXCells offers custom cell isolation services for a variety of cell types obtained from ethically procured donor tissues according to your specific criteria.
Documents	Primary Cells	iXCells Biotechnologies	View
CNS Brain-Related Products Flyer Accelerating neurological research, drug screening, and disease modelling with a wide range of Human iPSC-Derived Cells – supported by research publications and trusted by researchers, scientists, academia, and global organizations. Primary Cell Products designed to empower researchers with innovative solutions that accelerate drug discovery workflows, with a focus on neurodegenerative and central nervous system diseases.
Documents	Neuroscience	iXCells Biotechnologies	View
Product Catalogue 2023 Since its inception in 1998, AllCells has been providing primary cell products to support the cell and gene therapy industry. In 2022, AllCells joined Discovery Life Sciences to expand its capabilities and serve the entire cell and gene therapy continuum — from basic discovery through commercialisation. With more than 30 years of collective industry experience, AllCells and Discovery will focus on providing revolutionary products and services with greater speed and reliability.
Documents	Human Blood Products	AllCells	View
GMP Product Catalogue 2023 Sourcing high-quality cellular material is one of the biggest industry challenges for the development of cell and gene therapies. AllCells, a Discovery Life Sciences company, is the industry leader in providing GMP-compliant and RUO starting materials to support the full continuum of cell and gene therapy production – from basic discovery through commercialisation. Operating the largest and most diverse repository of healthy, recallable donors, AllCells is well-suited to fulfil a variety of donor attributes.
Documents	Human Blood Products	AllCells	View
Mobilized Leukopaks Product Catalogue Mobilized Leukopaks are apheresis products collected from healthy donors treated with different FDA-approved drugs to stimulate mobilization of CD34+ hematopoietic stem and progenitor cells (HSPCs) from the bone marrow to the peripheral blood. This procedure results in large-scale yields of single-donor CD34+ HSPCs, allowing for scalability and reproducibility of experiments by limiting the impact of donor-to-donor variability.
Documents	Human Blood Products	AllCells	View
BeCytes Biotechnologies Primary Liver Cells Video BeCytes Biotechnologies is a biotechnological company that offers products and services (CRO) based on tissue procurement, cell isolation and cell solutions for in vitro models for research purposes. BeCytes Biotechnologies offers an extensive portfolio of cryopreserved human and animal liver cells, including plateable and suspension hepatocytes, stellates, Kupffers, liver sinusoidal endothelial cells and sub-cellular liver fractions.
Videos	Primary Cells	BeCytes Biotechnologies	View
Single Domain Antibody Development Services ProSci offers single domain antibody development services. ProSci has 25+ years of developing antibodies, developed 20,000+ custom antibodies, and offers customisable services tailored to specific needs.
Documents	Antibodies	ProSci	View
Single Domain Antibodies Brochure The Single Doman Antibody (sdAb) from camelid, also known as VHH antibodies, provides cutting edge technology for antibody research. sdAbs lack light chains and are smaller and more stable than conventional antibodies, yet they possess fully functional antigen-binding capability. Due to its size (a mere 15 kDa), a single domain antibody is adept at reaching otherwise inaccessible epitopes.
Documents	Antibodies	ProSci	View
SARS-CoV-2 Pseudoviruses ProSci has developed SARS-CoV-2 pseudoviruses with a luciferase reporter allowing researchers to quickly build their own neutralization and inhibitor interaction assays. These pseudoviruses have been engineered to lack the appropriate coding for the virus to replicate.
Documents	COVID-19	ProSci	View
Single Domain Antibodies the Next Generation of Recombinant Antibodies Single domain antibodies (sdAbs) are small antigen-binding fragments with unique characteristics that make them useful alternatives to conventional antibodies and important tools in research, diagnostics and therapeutics.
Documents	Antibodies	ProSci	View
SARS-CoV-2 Open Reading Frames (ORFs) The SARS-CoV-2 virus which causes COVID-19 is comprised of 10 open reading frames (ORFs). Many of these create structural proteins and nonstructural proteins, but several of them generate unique proteins named after the ORF they are encoded by. Inhibiting some of these SARS-CoV-2 proteins which contribute to viral immune evasion could lead to faster clearing of SARS-CoV-2 infection by improving the hosts antiviral systems. ProScis catalogue has antibodies and recombinant proteins to many of the SARS-CoV-2 ORF accessory proteins.
Documents	COVID-19	ProSci	View
BeCytes Biotechnologies Primary Human Liver Cells Manual BeCytes Biotechnologies supports life science researchers developing preclinical studies, aimed to improve human health, by providing access to primary human liver cells.
Documents	Primary Cells	BeCytes Biotechnologies	View

First Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 Next Last Show Max.